[1]
N. . Pongener, V. . Visi, and R. . Ghatani, “Saroglitazar for the Management of Diabetic Dyslipidemia and Non-Alcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis”, IJMBS, vol. 9, no. 3, pp. 44–53, Jun. 2025.